Business Description
WooGene B&G Co Ltd
NAICS : 541940
SIC : 741
ISIN : KR7018620005
Compare
Compare
Traded in other countries / regions
018620.Korea Index Membership
KOSDAQ Composite Index IPO Date
2008-05-20Description
WooGene B&G Co Ltd manufactures and markets medicines for animals. The company plans to start new business that manufactures raw materials of medicines for human beings, microbial pesticides and functional health food.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | 4.04 | |||||
| Interest Coverage | 0.7 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.83 | |||||
| Beneish M-Score | -3.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.3 | |||||
| 3-Year EBITDA Growth Rate | 5.4 | |||||
| 3-Year EPS without NRI Growth Rate | 37.4 | |||||
| 3-Year FCF Growth Rate | 45 | |||||
| 3-Year Book Growth Rate | 2.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.71 | |||||
| 9-Day RSI | 34.93 | |||||
| 14-Day RSI | 38.68 | |||||
| 3-1 Month Momentum % | -0.86 | |||||
| 6-1 Month Momentum % | -11.49 | |||||
| 12-1 Month Momentum % | -20.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.25 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 102.74 | |||||
| Days Sales Outstanding | 52.21 | |||||
| Days Payable | 18.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -27.83 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.07 | |||||
| Operating Margin % | 3.28 | |||||
| Net Margin % | 2.12 | |||||
| FCF Margin % | -5 | |||||
| ROE % | 3.62 | |||||
| ROA % | 1.03 | |||||
| ROIC % | 2.57 | |||||
| 3-Year ROIIC % | -3.46 | |||||
| ROC (Joel Greenblatt) % | 7.82 | |||||
| ROCE % | 4.34 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.63 | |||||
| PS Ratio | 0.44 | |||||
| PB Ratio | 0.73 | |||||
| Price-to-Tangible-Book | 43.48 | |||||
| Price-to-Operating-Cash-Flow | 4.9 | |||||
| EV-to-EBIT | 20.32 | |||||
| EV-to-EBITDA | 10.16 | |||||
| EV-to-Revenue | 1.35 | |||||
| EV-to-FCF | -27.09 | |||||
| Price-to-GF-Value | 0.43 | |||||
| Price-to-Projected-FCF | 1.86 | |||||
| Price-to-Median-PS-Value | 0.24 | |||||
| Earnings Yield (Greenblatt) % | 4.92 | |||||
| FCF Yield % | -11.44 | |||||
| Forward Rate of Return (Yacktman) % | 3.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
WooGene B&G Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 58,639.504 | ||
| EPS (TTM) (â‚©) | 43 | ||
| Beta | 0.55 | ||
| 3-Year Sharpe Ratio | -1.12 | ||
| 3-Year Sortino Ratio | -1.23 | ||
| Volatility % | 15.75 | ||
| 14-Day RSI | 38.68 | ||
| 14-Day ATR (â‚©) | 18.77377 | ||
| 20-Day SMA (â‚©) | 905.55 | ||
| 12-1 Month Momentum % | -20.34 | ||
| 52-Week Range (â‚©) | 830 - 1216 | ||
| Shares Outstanding (Mil) | 28.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
WooGene B&G Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
WooGene B&G Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
WooGene B&G Co Ltd Frequently Asked Questions
What is WooGene B&G Co Ltd(XKRX:018620)'s stock price today?
The current price of XKRX:018620 is â‚©887.00. The 52 week high of XKRX:018620 is â‚©1216.00 and 52 week low is â‚©830.00.
When is next earnings date of WooGene B&G Co Ltd(XKRX:018620)?
The next earnings date of WooGene B&G Co Ltd(XKRX:018620) is .
Does WooGene B&G Co Ltd(XKRX:018620) pay dividends? If so, how much?
WooGene B&G Co Ltd(XKRX:018620) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers